Lyra Therapeutics
LYRA
trading on NASDAQ
since 2020
$28.86
(Δ 0%)
+$0.00 since open
Lyra Therapeutics is a biotechnology company dedicated to developing innovative therapies for central nervous system disorders, utilizing precision medicine approaches to address conditions such as depression and schizophrenia.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $22.70 | $34.00 | $22.51 | $116.36K | 6.12M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.13 | n/a | 10370.34 | -4831.15% | -4670.49% | 0% |